{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T10:01:32Z","timestamp":1768039292844,"version":"3.49.0"},"reference-count":28,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,2,1]]},"DOI":"10.2169\/internalmedicine.8568-21","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T22:09:48Z","timestamp":1637359788000},"page":"407-412","source":"Crossref","is-referenced-by-count":20,"title":["Acquired Thrombotic Thrombocytopenic Purpura Following BNT162b2 mRNA Coronavirus Disease Vaccination in a Japanese Patient"],"prefix":"10.2169","volume":"61","author":[{"given":"Kikuaki","family":"Yoshida","sequence":"first","affiliation":[{"name":"Department of Hematology\/Oncology, Wakayama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Sakaki","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Wakayama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoriko","family":"Matsuyama","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Wakayama Medical University, Japan"},{"name":"Department of General Internal Medicine, Hashimoto Municipal Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Mushino","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Wakayama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion Medicine, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sonoki","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Wakayama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Wakayama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol 21: 626-636, 2021.","DOI":"10.1038\/s41577-021-00592-1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Montgomery J, Ryan M, Engler R, et al. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiol 6: 1202-1206, 2021.","DOI":"10.1001\/jamacardio.2021.2833"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kim HW, Jenista ER, Wendell DC, et al. Patients with acute myocarditis following mRNA COVID-v9 vaccination. JAMA Cardiol 6: 1196-1201, 2021.","DOI":"10.1001\/jamacardio.2021.2828"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Muir KL, Kallam A, Koepsell SA, Gundabolu K. Thrombotic thrombocytopenia after Ad26.COV2.S vaccination. N Engl J Med 384: 1964-1965, 2021.","DOI":"10.1056\/NEJMc2105869"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Greinacher A, Thiele T, Warkentin TE, et al. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med 384: 2092-2101, 2021.","DOI":"10.1056\/NEJMoa2104840"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Schultz NH, S\u00f8rvoll IH, Michelsen AE, et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med 384: 2124-2130, 2021.","DOI":"10.1056\/NEJMoa2104882"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. See I, Su JR, Lale A, et al. US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021. JAMA 325: 2448-2456, 2021.","DOI":"10.1001\/jama.2021.7517"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. de Bruijn S, Maes MB, De Waele L, Vanhoorelbeke K, Gadisseur A. First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination. J Thromb Haemost 19: 2014-2018, 2021.","DOI":"10.1111\/jth.15418"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Al-Ahmad M, Al-Rasheed M, Shalaby NAB. Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccine. EJHaem 2: 534-536, 2021.","DOI":"10.1002\/jha2.219"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yocum A, Simon EL. Thrombotic thrombocytopenic purpura after Ad26.COV2-S vaccination. Am J Emerg Med 49: 441.e3-441.e4, 2021.","DOI":"10.1016\/j.ajem.2021.05.001"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Waqar SHB, Khan AA, Memon S. Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine. Int J Hematol 114: 626-629, 2021.","DOI":"10.1007\/s12185-021-03190-y"},{"key":"12","unstructured":"12. Ruhe J, Schnetzke U, Kentouche K, et al. Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine. Ann Hematol. Forthcoming."},{"key":"13","unstructured":"13. Giuffrida G, Condorelli A, Di Giorgio MA, et al. Immune-mediated thrombotic thrombocytopenic purpura following Pfizer-BioNTech COVID-19 vaccine. Haematologica. Forthcoming."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Maayan H, Kirgner I, Gutwein O, et al. Acquired thrombotic thrombocytopenic purpura: a rare disease associated with BNT162b2 vaccine. J Thromb Haemost 19: 2314-2317, 2021.","DOI":"10.1111\/jth.15420"},{"key":"15","unstructured":"15. Kirpalani A, Garabon J, Amos K, et al. Thrombotic thrombocytopenic purpura temporally associated with BNT162b2 vaccination in an adolescent successfully treated with caplacizumab. Br J Haematol. Forthcoming."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Chamarti K, Dar K, Reddy A, et al. Thrombotic thrombocytopenic purpura presentation in an elderly gentleman following COVID vaccine circumstances. Cureus 13: e16619, 2021.","DOI":"10.7759\/cureus.16619"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sissa C, Al-Khaffaf A, Frattini F, et al. Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine. Transfus Apher Sci 60: 103145, 2021.","DOI":"10.1016\/j.transci.2021.103145"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yava\u015fo\u011flu \u0130. Vaccination and thrombotic thrombocytopenic purpura. Turk J Haematol 37: 218-219, 2020.","DOI":"10.4274\/tjh.galenos.2020.2020.0060"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Brown RC, Blecher TE, French EA, Toghill PJ. Thrombotic thrombocytopenic purpura after influenza vaccination. Br Med J 2: 303, 1973.","DOI":"10.1136\/bmj.2.5861.303-a"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kadikoylu G, Yavasoglu I, Bolaman Z. Rabies vaccine-associated thrombotic thrombocytopenic purpura. Transfus Med 24: 428-429, 2014.","DOI":"10.1111\/tme.12160"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kojima Y, Ohashi H, Nakamura T, et al. Acute thrombotic thrombocytopenic purpura after pneumococcal vaccination. Blood Coagul Fibrinolysis 25: 512-514, 2014.","DOI":"10.1097\/MBC.0000000000000058"},{"key":"22","unstructured":"22. Ramakrishnan N, Parker LP. Thrombotic thrombocytopenic purpura following influenza vaccination - a brief case report. Conn Med 62: 587-588, 1998."},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Dias PJ, Gopal S. Refractory thrombotic thrombocytopenic purpura following influenza vaccination. Anaesthesia 64: 444-446, 2009.","DOI":"10.1111\/j.1365-2044.2008.05823.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Hermann R, Pfeil A, Busch M, et al. Very severe thrombotic thrombocytopenic purpura (TTP) after H1N1 vaccination. Med Klin (Munich) 105: 663-668, 2010.","DOI":"10.1007\/s00063-010-1107-6"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Scully M, Singh D, Lown R, et al. Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N Engl J Med 384: 2202-2211, 2021.","DOI":"10.1056\/NEJMoa2105385"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Nazy I, Sachs UJ, Arnold DM, et al. Recommendations for the clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia (VITT) for SARS-CoV-2 infections: Communication from the ISTH SSC Subcommittee on Platelet Immunology. J Thromb Haemost 19: 1585-1588, 2021.","DOI":"10.1111\/jth.15341"},{"key":"27","unstructured":"27. World Health Organization. Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria\u2122, SII COVISHIELD\u2122) [Internet]. 2021 July 30 [cited 2021 Aug 20]. [1-12]. Available from: WHO\/2019-nCov\/vaccines\/SAGE_recommendation\/AZD1222\/2021.3-eng.pdf"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Simpson CR, Shi T, Vasileiou E, et al. First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nat Med 27: 1290-1297, 2021.","DOI":"10.1038\/s41591-021-01408-4"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/3\/61_8568-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:08:35Z","timestamp":1715231315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/3\/61_8568-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8568-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"article-number":"8568-21"}}